Influence of vinblastine on DNA parameters and multidrug resistance in renal cell carcinoma in vitro

Urological Research

Volumn 26, Issue 2, 1998, Pages 123-127

  Domagk, D ^a   Bluthner Hassler C ^a   Kugler, A ^a   Kallerhoff, M ^a   Ringert, R H ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

DNA parameters; MTT assay; Multidrug resistance; Renal cell carcinoma; Therapy; Vinblastine

Indexed keywords

CELL DNA; VINBLASTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL SURVIVAL; CONTROLLED STUDY; DNA DETERMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, RENAL CELL; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; DRUG RESISTANCE, MULTIPLE; FLOW CYTOMETRY; HUMANS; KIDNEY NEOPLASMS; P-GLYCOPROTEIN; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED; VINBLASTINE;

EID: 0031969069     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400050034     Document Type: Article

References (31)

1. Beck WT (1990) Mechanism of multidrug-resistance in human tumor cells: the roles of P-glycoprotein. DNA topoisomerase II, and other factors. Cancer Treat Rev 17 [Suppl A]:11
2. Beraerat JP, Herbrecht R, Duflour P, Jacqmin D, Bollak C, Prevot G, Bailly G, De Garis S, Juraschek F, Oberling F (1988) Combination of recombinant interferon-alpha-2a and vinblastine in advanced renal cell cancer. Cancer 62:2320
3. Bland JM, Altman DG (1995) Calculating correlation coefficients with repeated observations. I. Correlation within subjects. BMJ 310: 446
4. Bosanquet AG (1994) Short-term in vitro drug sensitivity tests for cancer chemotherapy: a summary of correlations of test result with both patient response and survival. FORUM Trends Exp Clin Med 4: 179
5. Briffod M, Spyratos F, Tubiana-Huhn M , Pallud C, Mayras C, Filleul A, et al (1989) Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma: cytomorphologic changes. initial tumor ploidy, and tumor regression. Cancer 63:631
6. Büchner T, Dittrich W, Göhde W (1971) Die Impulszytophotometrie in der hämatoloaischen Cytologie. Klin Wochenschr 49:1090
7. Cordon-Cardo C, Lloyd FO, Finstad CL (1986) Immunoanatomic distribution of blood group antigens in the human urinary tract: influence of secretor status. Lab Invest 55:444
8. Damiani D, Michieli M, Michelutti A, Melli C, Cerno M, Baccarani M (1993) D-Verapamil downmodulates p170-associated resistance to doxorubicin, daunarubicin and idarubicin. Anticancer Drugs 4:173
9. Dutt A, Heath LA, Nelson JA (1994) P-glycoprotein and organic cation secretion by the mammalian kidney. J Pharmacol Exp Ther 269:1254
10. Efferth T, Voim M (1992) Immunocytochemical detection of oncoproteins in animal and human tumor lines with acquired or inherent multidrug resistance. Cancer Detect Prev 16: 237
11. Fossa SD, De Garis ST, Heier MS, Flokkmann A, Lien HH, Salveson A, et al (1986) Recombinant interferon-alpha-2a with or without vinblastine in metastatic renal cell carcinoma. Cancer 57:1700
12. Giaretti W, Santi L (1990) Tumor progression by DNA flow cytometry in human colorectal cancer. Int J Cancer 19:597
13. Hoban PR, Robson CN, Davies SM, Hall AG, Cattan AR, Hickson ID, et al (1992) Reduced topoisomerase II and elevated alpha class glutathione-S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C. Biochem Pharmacol 43.685
14. Hrusheksy BY, Murphy GP (1977) Current studies of the therapy of advanced renal cell carcinoma. J Surg Oncol 9:277
15. Kleinhans G (1989) DNS-Impulszytophotometric in der urologischen Onkologie. Zuckschwerdt, Muncihen
16. Leyland-Jones B, Dalton W, Fisher GA, Sikic BI (1993) Reversal of multidrug resistance to cancer chemotherapy. Cancer 72:3384
17. Maier G, Heissler HE, Blech M, Schroter W (1988) DNA-Profile, Rezidivrate und Progression beim oberflachlichen G2-Karzinom der Harnblase. Urologe A 27:173
18. Marino PA, Gottesman MM, Pastan I (1990) Regulation of multidrus-resistance genein regenerating rat liver. Cell Growth Differ 1:57
19. Michelson S, Slate D (1994) A mathematical model for the inhibition of the multidrug resistance-associated P-glycoprotein pump. Bull Math Biol 56:207
20. Mickisch GH, Schroeder FH (1994) From laboratory expertise to clinical practice: multidrug-resistance-based gene therapy becomes available for urologists. World J Urol 12:104
21. Mickisch G, Roehrich K, Koessig J, Forster S, Tschada R, Alken P (1990) Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol 144: 755
22. Miller BM, Zitzelsberger HF, Weier HU, Adler ID (1991) Classification of micronuclei in murine erythrocytes: immunofluorescent staining using CREST antibodies compared to in situ hybridization with biotinylated gamma satellite DNA. Mutagenesis 6:297
23. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55
24. Osborne CK (1989) DNA flow cytometry in early breast cancer: a step in the right direction (editorial). J Natl Cancer Inst 81:1344
25. Pauwels O, Kiss R (1991) Digital morphonuclear analyses of sensitive versus resistant neoplastic cells to vinca-alkaloid, alkylating and intercalating drugs. Cytometry 12:388
26. Remvikos Y, Beuzeboc P, Zadjela A, Voillemot M, Magdelénat H, Pouillart P (1989) Correlation of pretreatment proliferative activity with the response of cytotoxic chemotherapy. J Natl Cancer Inst 81:1383
27. SAS Institute (1987) SAS user's guide, version 6 SAS Institute, Cary, NC
28. Severin E, Meier EM, Willers R (1984) Flow cytometric analysis of mouse hepatocyte ploidy. I. Preparative and mathematical protocol. Cell Tissue Res 238.643
29. Spyratos F, Briffod M, Tubiana-Hulin M, Andrieu C, Mayras C, Pallud C, et al (1992) Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. Cancer 69:470
30. Thorgeirsson SS, Huber BE, Sorrell S, Fojo A, Pastan I, Gottesman MM (1986) Expression of the multidrug resistant gene in hepatocarcinogenesis and regenerating rat liver. Science 236:1120
31. Volm M, Kastel M, Mattern J, Efferth T (1993) Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncosene products in renal cell carcinomas. Cancer 71: 3981